nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—ABCB1—esophageal cancer	0.344	1	CbGaD
Felodipine—CACNA2D2—neck—esophageal cancer	0.0061	0.0542	CbGeAlD
Felodipine—TNNC2—lymph node—esophageal cancer	0.00425	0.0378	CbGeAlD
Felodipine—PDE1A—smooth muscle tissue—esophageal cancer	0.00415	0.0369	CbGeAlD
Felodipine—CALM2—exocrine gland—esophageal cancer	0.00388	0.0344	CbGeAlD
Felodipine—CALM1—exocrine gland—esophageal cancer	0.00386	0.0343	CbGeAlD
Felodipine—CACNA1H—smooth muscle tissue—esophageal cancer	0.00324	0.0288	CbGeAlD
Felodipine—TNNC1—lung—esophageal cancer	0.00313	0.0278	CbGeAlD
Felodipine—PDE1A—lung—esophageal cancer	0.00274	0.0243	CbGeAlD
Felodipine—Hepatitis cholestatic—Capecitabine—esophageal cancer	0.00271	0.0295	CcSEcCtD
Felodipine—CACNA2D2—lung—esophageal cancer	0.00264	0.0234	CbGeAlD
Felodipine—Allergic cutaneous angiitis—Methotrexate—esophageal cancer	0.00256	0.0279	CcSEcCtD
Felodipine—CALM2—neck—esophageal cancer	0.00248	0.022	CbGeAlD
Felodipine—CACNA1C—smooth muscle tissue—esophageal cancer	0.00247	0.0219	CbGeAlD
Felodipine—CALM1—neck—esophageal cancer	0.00247	0.0219	CbGeAlD
Felodipine—CACNB2—digestive system—esophageal cancer	0.00242	0.0215	CbGeAlD
Felodipine—NR3C2—bronchus—esophageal cancer	0.0023	0.0204	CbGeAlD
Felodipine—NR3C2—smooth muscle tissue—esophageal cancer	0.00225	0.02	CbGeAlD
Felodipine—PDE1B—lymph node—esophageal cancer	0.00223	0.0199	CbGeAlD
Felodipine—Joint swelling—Capecitabine—esophageal cancer	0.00223	0.0243	CcSEcCtD
Felodipine—Amlodipine—CA1—esophageal cancer	0.00217	0.238	CrCbGaD
Felodipine—TNNC1—lymph node—esophageal cancer	0.00214	0.019	CbGeAlD
Felodipine—CALM3—bronchus—esophageal cancer	0.00211	0.0188	CbGeAlD
Felodipine—CALM3—smooth muscle tissue—esophageal cancer	0.00207	0.0184	CbGeAlD
Felodipine—NR3C2—trachea—esophageal cancer	0.00206	0.0183	CbGeAlD
Felodipine—CACNB2—lung—esophageal cancer	0.00202	0.0179	CbGeAlD
Felodipine—Sneezing—Capecitabine—esophageal cancer	0.00197	0.0215	CcSEcCtD
Felodipine—CACNA1C—digestive system—esophageal cancer	0.00195	0.0173	CbGeAlD
Felodipine—CALM3—trachea—esophageal cancer	0.0019	0.0169	CbGeAlD
Felodipine—CACNA2D1—lung—esophageal cancer	0.0019	0.0168	CbGeAlD
Felodipine—PDE1A—lymph node—esophageal cancer	0.00187	0.0166	CbGeAlD
Felodipine—Rhinorrhoea—Cisplatin—esophageal cancer	0.00183	0.0199	CcSEcCtD
Felodipine—CACNA2D2—lymph node—esophageal cancer	0.0018	0.016	CbGeAlD
Felodipine—NR3C2—digestive system—esophageal cancer	0.00177	0.0158	CbGeAlD
Felodipine—CACNA1D—lung—esophageal cancer	0.00176	0.0157	CbGeAlD
Felodipine—Loss of libido—Methotrexate—esophageal cancer	0.00176	0.0192	CcSEcCtD
Felodipine—Tenderness—Cisplatin—esophageal cancer	0.0017	0.0185	CcSEcCtD
Felodipine—CALM2—epithelium—esophageal cancer	0.00169	0.015	CbGeAlD
Felodipine—CALM1—epithelium—esophageal cancer	0.00168	0.0149	CbGeAlD
Felodipine—CALM2—bronchus—esophageal cancer	0.00166	0.0148	CbGeAlD
Felodipine—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.00166	0.0181	CcSEcCtD
Felodipine—CALM1—bronchus—esophageal cancer	0.00165	0.0147	CbGeAlD
Felodipine—CACNA1C—lung—esophageal cancer	0.00163	0.0145	CbGeAlD
Felodipine—CALM2—smooth muscle tissue—esophageal cancer	0.00162	0.0144	CbGeAlD
Felodipine—CALM1—smooth muscle tissue—esophageal cancer	0.00162	0.0144	CbGeAlD
Felodipine—CALM2—trachea—esophageal cancer	0.00149	0.0132	CbGeAlD
Felodipine—CALM1—trachea—esophageal cancer	0.00148	0.0132	CbGeAlD
Felodipine—NR3C2—lung—esophageal cancer	0.00148	0.0132	CbGeAlD
Felodipine—CACNA1H—lymph node—esophageal cancer	0.00146	0.013	CbGeAlD
Felodipine—Body temperature increased—Carboplatin—esophageal cancer	0.00143	0.0155	CcSEcCtD
Felodipine—CACNB2—lymph node—esophageal cancer	0.00138	0.0123	CbGeAlD
Felodipine—Nilvadipine—CYP2A6—esophageal cancer	0.00137	0.15	CrCbGaD
Felodipine—CALM3—lung—esophageal cancer	0.00136	0.0121	CbGeAlD
Felodipine—Tingling sensation—Capecitabine—esophageal cancer	0.00136	0.0148	CcSEcCtD
Felodipine—Rhinorrhoea—Capecitabine—esophageal cancer	0.00135	0.0147	CcSEcCtD
Felodipine—Extrasystoles—Capecitabine—esophageal cancer	0.0013	0.0141	CcSEcCtD
Felodipine—CACNA2D1—lymph node—esophageal cancer	0.0013	0.0115	CbGeAlD
Felodipine—CALM2—digestive system—esophageal cancer	0.00128	0.0114	CbGeAlD
Felodipine—CALM1—digestive system—esophageal cancer	0.00128	0.0113	CbGeAlD
Felodipine—Contusion—Capecitabine—esophageal cancer	0.00125	0.0136	CcSEcCtD
Felodipine—Polyuria—Cisplatin—esophageal cancer	0.00123	0.0133	CcSEcCtD
Felodipine—CACNA1D—lymph node—esophageal cancer	0.00121	0.0107	CbGeAlD
Felodipine—Amlodipine—CYP2A6—esophageal cancer	0.00118	0.129	CrCbGaD
Felodipine—CACNA1C—lymph node—esophageal cancer	0.00111	0.0099	CbGeAlD
Felodipine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.0011	0.012	CcSEcCtD
Felodipine—CALM2—lung—esophageal cancer	0.00107	0.00952	CbGeAlD
Felodipine—CALM1—lung—esophageal cancer	0.00107	0.00948	CbGeAlD
Felodipine—Nifedipine—ABCC2—esophageal cancer	0.00107	0.117	CrCbGaD
Felodipine—Influenza like illness—Capecitabine—esophageal cancer	0.00106	0.0116	CcSEcCtD
Felodipine—Nifedipine—CYP2A6—esophageal cancer	0.00105	0.116	CrCbGaD
Felodipine—Face oedema—Cisplatin—esophageal cancer	0.00104	0.0113	CcSEcCtD
Felodipine—Irritability—Cisplatin—esophageal cancer	0.00103	0.0112	CcSEcCtD
Felodipine—NR3C2—lymph node—esophageal cancer	0.00101	0.00901	CbGeAlD
Felodipine—Urine output increased—Capecitabine—esophageal cancer	0.000988	0.0108	CcSEcCtD
Felodipine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000983	0.0107	CcSEcCtD
Felodipine—Cramp muscle—Cisplatin—esophageal cancer	0.000969	0.0106	CcSEcCtD
Felodipine—Nasopharyngitis—Cisplatin—esophageal cancer	0.000963	0.0105	CcSEcCtD
Felodipine—CYP3A5—digestive system—esophageal cancer	0.000959	0.00853	CbGeAlD
Felodipine—CYP2C9—digestive system—esophageal cancer	0.000944	0.00839	CbGeAlD
Felodipine—CALM3—lymph node—esophageal cancer	0.000933	0.00829	CbGeAlD
Felodipine—Polyuria—Capecitabine—esophageal cancer	0.000904	0.00984	CcSEcCtD
Felodipine—Swelling—Capecitabine—esophageal cancer	0.0009	0.00979	CcSEcCtD
Felodipine—Abdominal discomfort—Cisplatin—esophageal cancer	0.000892	0.00971	CcSEcCtD
Felodipine—Libido decreased—Capecitabine—esophageal cancer	0.000856	0.00931	CcSEcCtD
Felodipine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00081	0.00881	CcSEcCtD
Felodipine—CYP3A5—lung—esophageal cancer	0.000801	0.00712	CbGeAlD
Felodipine—Pain in extremity—Capecitabine—esophageal cancer	0.000794	0.00864	CcSEcCtD
Felodipine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000787	0.00857	CcSEcCtD
Felodipine—Face oedema—Capecitabine—esophageal cancer	0.000766	0.00834	CcSEcCtD
Felodipine—Bradycardia—Cisplatin—esophageal cancer	0.000758	0.00825	CcSEcCtD
Felodipine—Irritability—Capecitabine—esophageal cancer	0.000757	0.00824	CcSEcCtD
Felodipine—Urine output increased—Methotrexate—esophageal cancer	0.000736	0.00801	CcSEcCtD
Felodipine—CALM2—lymph node—esophageal cancer	0.000733	0.00651	CbGeAlD
Felodipine—CALM1—lymph node—esophageal cancer	0.000729	0.00648	CbGeAlD
Felodipine—Gynaecomastia—Methotrexate—esophageal cancer	0.000728	0.00792	CcSEcCtD
Felodipine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000725	0.00789	CcSEcCtD
Felodipine—CYP3A4—digestive system—esophageal cancer	0.00072	0.0064	CbGeAlD
Felodipine—Visual impairment—Cisplatin—esophageal cancer	0.000718	0.00781	CcSEcCtD
Felodipine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00071	0.00772	CcSEcCtD
Felodipine—CYP2D6—digestive system—esophageal cancer	0.000708	0.0063	CbGeAlD
Felodipine—Flushing—Cisplatin—esophageal cancer	0.000691	0.00752	CcSEcCtD
Felodipine—Influenza—Capecitabine—esophageal cancer	0.000686	0.00746	CcSEcCtD
Felodipine—Polyuria—Methotrexate—esophageal cancer	0.000673	0.00732	CcSEcCtD
Felodipine—ABCB1—epithelium—esophageal cancer	0.00067	0.00595	CbGeAlD
Felodipine—Angina pectoris—Capecitabine—esophageal cancer	0.000668	0.00727	CcSEcCtD
Felodipine—Arrhythmia—Cisplatin—esophageal cancer	0.000665	0.00724	CcSEcCtD
Felodipine—Bronchitis—Capecitabine—esophageal cancer	0.00066	0.00718	CcSEcCtD
Felodipine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000658	0.00716	CcSEcCtD
Felodipine—Erythema—Cisplatin—esophageal cancer	0.000648	0.00706	CcSEcCtD
Felodipine—Dysuria—Capecitabine—esophageal cancer	0.000641	0.00698	CcSEcCtD
Felodipine—Flatulence—Cisplatin—esophageal cancer	0.000639	0.00695	CcSEcCtD
Felodipine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000637	0.00694	CcSEcCtD
Felodipine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000626	0.00681	CcSEcCtD
Felodipine—Visual disturbance—Methotrexate—esophageal cancer	0.000623	0.00678	CcSEcCtD
Felodipine—Muscle spasms—Cisplatin—esophageal cancer	0.000623	0.00678	CcSEcCtD
Felodipine—Tremor—Cisplatin—esophageal cancer	0.000607	0.00661	CcSEcCtD
Felodipine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000603	0.00656	CcSEcCtD
Felodipine—Anaemia—Cisplatin—esophageal cancer	0.000599	0.00652	CcSEcCtD
Felodipine—ABCB1—trachea—esophageal cancer	0.000592	0.00527	CbGeAlD
Felodipine—Epistaxis—Capecitabine—esophageal cancer	0.000577	0.00628	CcSEcCtD
Felodipine—Irritability—Methotrexate—esophageal cancer	0.000564	0.00614	CcSEcCtD
Felodipine—Bradycardia—Capecitabine—esophageal cancer	0.000559	0.00608	CcSEcCtD
Felodipine—Myalgia—Cisplatin—esophageal cancer	0.000552	0.00601	CcSEcCtD
Felodipine—Pharyngitis—Capecitabine—esophageal cancer	0.000545	0.00593	CcSEcCtD
Felodipine—Nisoldipine—ABCB1—esophageal cancer	0.000544	0.0598	CrCbGaD
Felodipine—Oedema peripheral—Capecitabine—esophageal cancer	0.000541	0.00589	CcSEcCtD
Felodipine—Visual impairment—Capecitabine—esophageal cancer	0.000529	0.00576	CcSEcCtD
Felodipine—Erythema multiforme—Capecitabine—esophageal cancer	0.000519	0.00565	CcSEcCtD
Felodipine—Tachycardia—Cisplatin—esophageal cancer	0.000516	0.00562	CcSEcCtD
Felodipine—ABCB1—digestive system—esophageal cancer	0.00051	0.00453	CbGeAlD
Felodipine—Flushing—Capecitabine—esophageal cancer	0.00051	0.00555	CcSEcCtD
Felodipine—Nitrendipine—ABCB1—esophageal cancer	0.000509	0.0559	CrCbGaD
Felodipine—Arrhythmia—Capecitabine—esophageal cancer	0.00049	0.00534	CcSEcCtD
Felodipine—Abdominal discomfort—Methotrexate—esophageal cancer	0.00049	0.00533	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000482	0.00525	CcSEcCtD
Felodipine—Erythema—Capecitabine—esophageal cancer	0.000478	0.0052	CcSEcCtD
Felodipine—Dysuria—Methotrexate—esophageal cancer	0.000477	0.0052	CcSEcCtD
Felodipine—Paraesthesia—Cisplatin—esophageal cancer	0.000475	0.00517	CcSEcCtD
Felodipine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000475	0.00516	CcSEcCtD
Felodipine—Dyspnoea—Cisplatin—esophageal cancer	0.000472	0.00513	CcSEcCtD
Felodipine—Flatulence—Capecitabine—esophageal cancer	0.000471	0.00513	CcSEcCtD
Felodipine—Erectile dysfunction—Methotrexate—esophageal cancer	0.00047	0.00512	CcSEcCtD
Felodipine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000466	0.00507	CcSEcCtD
Felodipine—Back pain—Capecitabine—esophageal cancer	0.000462	0.00503	CcSEcCtD
Felodipine—Muscle spasms—Capecitabine—esophageal cancer	0.000459	0.005	CcSEcCtD
Felodipine—Tremor—Capecitabine—esophageal cancer	0.000448	0.00487	CcSEcCtD
Felodipine—Anaemia—Capecitabine—esophageal cancer	0.000442	0.00481	CcSEcCtD
Felodipine—Amlodipine—ABCB1—esophageal cancer	0.000438	0.0482	CrCbGaD
Felodipine—Feeling abnormal—Cisplatin—esophageal cancer	0.000436	0.00475	CcSEcCtD
Felodipine—Epistaxis—Methotrexate—esophageal cancer	0.000429	0.00467	CcSEcCtD
Felodipine—Vertigo—Capecitabine—esophageal cancer	0.000429	0.00467	CcSEcCtD
Felodipine—Syncope—Capecitabine—esophageal cancer	0.000429	0.00466	CcSEcCtD
Felodipine—ABCB1—lung—esophageal cancer	0.000426	0.00378	CbGeAlD
Felodipine—Palpitations—Capecitabine—esophageal cancer	0.000422	0.0046	CcSEcCtD
Felodipine—Loss of consciousness—Capecitabine—esophageal cancer	0.00042	0.00457	CcSEcCtD
Felodipine—Body temperature increased—Cisplatin—esophageal cancer	0.000418	0.00455	CcSEcCtD
Felodipine—Cough—Capecitabine—esophageal cancer	0.000417	0.00454	CcSEcCtD
Felodipine—Arthralgia—Capecitabine—esophageal cancer	0.000407	0.00443	CcSEcCtD
Felodipine—Chest pain—Capecitabine—esophageal cancer	0.000407	0.00443	CcSEcCtD
Felodipine—Myalgia—Capecitabine—esophageal cancer	0.000407	0.00443	CcSEcCtD
Felodipine—Pharyngitis—Methotrexate—esophageal cancer	0.000406	0.00441	CcSEcCtD
Felodipine—Dry mouth—Capecitabine—esophageal cancer	0.000398	0.00433	CcSEcCtD
Felodipine—Visual impairment—Methotrexate—esophageal cancer	0.000394	0.00429	CcSEcCtD
Felodipine—Confusional state—Capecitabine—esophageal cancer	0.000393	0.00428	CcSEcCtD
Felodipine—Nifedipine—ABCB1—esophageal cancer	0.000392	0.0431	CrCbGaD
Felodipine—Hypersensitivity—Cisplatin—esophageal cancer	0.00039	0.00424	CcSEcCtD
Felodipine—Erythema multiforme—Methotrexate—esophageal cancer	0.000386	0.00421	CcSEcCtD
Felodipine—Nicardipine—ABCB1—esophageal cancer	0.000386	0.0424	CrCbGaD
Felodipine—Shock—Capecitabine—esophageal cancer	0.000384	0.00418	CcSEcCtD
Felodipine—Tachycardia—Capecitabine—esophageal cancer	0.000381	0.00414	CcSEcCtD
Felodipine—Asthenia—Cisplatin—esophageal cancer	0.00038	0.00413	CcSEcCtD
Felodipine—Diarrhoea—Cisplatin—esophageal cancer	0.000362	0.00394	CcSEcCtD
Felodipine—Erythema—Methotrexate—esophageal cancer	0.000356	0.00387	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000355	0.00387	CcSEcCtD
Felodipine—Insomnia—Capecitabine—esophageal cancer	0.000353	0.00384	CcSEcCtD
Felodipine—Paraesthesia—Capecitabine—esophageal cancer	0.00035	0.00381	CcSEcCtD
Felodipine—Dyspnoea—Capecitabine—esophageal cancer	0.000348	0.00378	CcSEcCtD
Felodipine—Back pain—Methotrexate—esophageal cancer	0.000344	0.00375	CcSEcCtD
Felodipine—Dyspepsia—Capecitabine—esophageal cancer	0.000343	0.00374	CcSEcCtD
Felodipine—Vomiting—Cisplatin—esophageal cancer	0.000336	0.00366	CcSEcCtD
Felodipine—Fatigue—Capecitabine—esophageal cancer	0.000336	0.00366	CcSEcCtD
Felodipine—Rash—Cisplatin—esophageal cancer	0.000334	0.00363	CcSEcCtD
Felodipine—Constipation—Capecitabine—esophageal cancer	0.000334	0.00363	CcSEcCtD
Felodipine—Dermatitis—Cisplatin—esophageal cancer	0.000333	0.00363	CcSEcCtD
Felodipine—Anaemia—Methotrexate—esophageal cancer	0.000329	0.00358	CcSEcCtD
Felodipine—Feeling abnormal—Capecitabine—esophageal cancer	0.000321	0.0035	CcSEcCtD
Felodipine—Vertigo—Methotrexate—esophageal cancer	0.00032	0.00348	CcSEcCtD
Felodipine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000319	0.00347	CcSEcCtD
Felodipine—Nausea—Cisplatin—esophageal cancer	0.000314	0.00342	CcSEcCtD
Felodipine—Cough—Methotrexate—esophageal cancer	0.00031	0.00338	CcSEcCtD
Felodipine—Urticaria—Capecitabine—esophageal cancer	0.00031	0.00337	CcSEcCtD
Felodipine—Body temperature increased—Capecitabine—esophageal cancer	0.000308	0.00336	CcSEcCtD
Felodipine—Abdominal pain—Capecitabine—esophageal cancer	0.000308	0.00336	CcSEcCtD
Felodipine—Arthralgia—Methotrexate—esophageal cancer	0.000303	0.0033	CcSEcCtD
Felodipine—Myalgia—Methotrexate—esophageal cancer	0.000303	0.0033	CcSEcCtD
Felodipine—Chest pain—Methotrexate—esophageal cancer	0.000303	0.0033	CcSEcCtD
Felodipine—Confusional state—Methotrexate—esophageal cancer	0.000293	0.00319	CcSEcCtD
Felodipine—ABCB1—lymph node—esophageal cancer	0.000291	0.00259	CbGeAlD
Felodipine—Hypersensitivity—Capecitabine—esophageal cancer	0.000287	0.00313	CcSEcCtD
Felodipine—Asthenia—Capecitabine—esophageal cancer	0.00028	0.00305	CcSEcCtD
Felodipine—Pruritus—Capecitabine—esophageal cancer	0.000276	0.003	CcSEcCtD
Felodipine—Diarrhoea—Capecitabine—esophageal cancer	0.000267	0.0029	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000265	0.00288	CcSEcCtD
Felodipine—Insomnia—Methotrexate—esophageal cancer	0.000263	0.00286	CcSEcCtD
Felodipine—Paraesthesia—Methotrexate—esophageal cancer	0.000261	0.00284	CcSEcCtD
Felodipine—Dyspnoea—Methotrexate—esophageal cancer	0.000259	0.00282	CcSEcCtD
Felodipine—Somnolence—Methotrexate—esophageal cancer	0.000258	0.00281	CcSEcCtD
Felodipine—Dizziness—Capecitabine—esophageal cancer	0.000258	0.00281	CcSEcCtD
Felodipine—Dyspepsia—Methotrexate—esophageal cancer	0.000256	0.00278	CcSEcCtD
Felodipine—Fatigue—Methotrexate—esophageal cancer	0.00025	0.00272	CcSEcCtD
Felodipine—Vomiting—Capecitabine—esophageal cancer	0.000248	0.0027	CcSEcCtD
Felodipine—Rash—Capecitabine—esophageal cancer	0.000246	0.00268	CcSEcCtD
Felodipine—Dermatitis—Capecitabine—esophageal cancer	0.000246	0.00267	CcSEcCtD
Felodipine—Headache—Capecitabine—esophageal cancer	0.000244	0.00266	CcSEcCtD
Felodipine—Feeling abnormal—Methotrexate—esophageal cancer	0.000239	0.0026	CcSEcCtD
Felodipine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000237	0.00258	CcSEcCtD
Felodipine—Nausea—Capecitabine—esophageal cancer	0.000232	0.00252	CcSEcCtD
Felodipine—Urticaria—Methotrexate—esophageal cancer	0.000231	0.00251	CcSEcCtD
Felodipine—Abdominal pain—Methotrexate—esophageal cancer	0.00023	0.0025	CcSEcCtD
Felodipine—Body temperature increased—Methotrexate—esophageal cancer	0.00023	0.0025	CcSEcCtD
Felodipine—Hypersensitivity—Methotrexate—esophageal cancer	0.000214	0.00233	CcSEcCtD
Felodipine—Asthenia—Methotrexate—esophageal cancer	0.000208	0.00227	CcSEcCtD
Felodipine—Pruritus—Methotrexate—esophageal cancer	0.000205	0.00224	CcSEcCtD
Felodipine—Diarrhoea—Methotrexate—esophageal cancer	0.000199	0.00216	CcSEcCtD
Felodipine—Dizziness—Methotrexate—esophageal cancer	0.000192	0.00209	CcSEcCtD
Felodipine—Vomiting—Methotrexate—esophageal cancer	0.000185	0.00201	CcSEcCtD
Felodipine—Rash—Methotrexate—esophageal cancer	0.000183	0.00199	CcSEcCtD
Felodipine—Dermatitis—Methotrexate—esophageal cancer	0.000183	0.00199	CcSEcCtD
Felodipine—Headache—Methotrexate—esophageal cancer	0.000182	0.00198	CcSEcCtD
Felodipine—Nausea—Methotrexate—esophageal cancer	0.000172	0.00188	CcSEcCtD
Felodipine—CALM3—Innate Immune System—EP300—esophageal cancer	1.2e-05	2.72e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—CDKN1A—esophageal cancer	1.2e-05	2.72e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—HMOX1—esophageal cancer	1.2e-05	2.71e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—HMOX1—esophageal cancer	1.2e-05	2.71e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PSME1—esophageal cancer	1.2e-05	2.71e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PSME2—esophageal cancer	1.2e-05	2.71e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.2e-05	2.7e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—ABCB1—esophageal cancer	1.19e-05	2.69e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PSME1—esophageal cancer	1.19e-05	2.68e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PSME2—esophageal cancer	1.19e-05	2.68e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—NOTCH2—esophageal cancer	1.19e-05	2.68e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.18e-05	2.67e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.18e-05	2.66e-05	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—CDKN1A—esophageal cancer	1.18e-05	2.66e-05	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—CDKN1A—esophageal cancer	1.18e-05	2.66e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—TLR4—esophageal cancer	1.17e-05	2.64e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—TLR4—esophageal cancer	1.17e-05	2.64e-05	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—EP300—esophageal cancer	1.17e-05	2.63e-05	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—EP300—esophageal cancer	1.17e-05	2.63e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—HIF1A—esophageal cancer	1.16e-05	2.63e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—ABCB1—esophageal cancer	1.15e-05	2.6e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—ABCB1—esophageal cancer	1.15e-05	2.6e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—NOTCH2—esophageal cancer	1.15e-05	2.59e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—NOTCH2—esophageal cancer	1.15e-05	2.59e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.15e-05	2.59e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—EP300—esophageal cancer	1.14e-05	2.58e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—HIF1A—esophageal cancer	1.13e-05	2.54e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—HIF1A—esophageal cancer	1.13e-05	2.54e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.11e-05	2.5e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.1e-05	2.48e-05	CbGpPWpGaD
Felodipine—CACNB2—Metabolism—PIK3CA—esophageal cancer	1.09e-05	2.47e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—TPI1—esophageal cancer	1.09e-05	2.47e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.09e-05	2.47e-05	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—MYC—esophageal cancer	1.09e-05	2.46e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.08e-05	2.44e-05	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—EGFR—esophageal cancer	1.07e-05	2.41e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.06e-05	2.39e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—NOS2—esophageal cancer	1.06e-05	2.39e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TGFBR2—esophageal cancer	1.05e-05	2.38e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—NOTCH1—esophageal cancer	1.05e-05	2.37e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.05e-05	2.37e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.04e-05	2.34e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.04e-05	2.34e-05	CbGpPWpGaD
Felodipine—CACNA1D—Metabolism—PIK3CA—esophageal cancer	1.04e-05	2.34e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—CASP8—esophageal cancer	1.03e-05	2.34e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.03e-05	2.33e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.03e-05	2.33e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—CREBBP—esophageal cancer	1.03e-05	2.33e-05	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—EGFR—esophageal cancer	1.03e-05	2.32e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.02e-05	2.31e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—NOS2—esophageal cancer	1.02e-05	2.31e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—NOS2—esophageal cancer	1.02e-05	2.31e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TGFBR2—esophageal cancer	1.02e-05	2.3e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TGFBR2—esophageal cancer	1.02e-05	2.3e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—NOTCH1—esophageal cancer	1.01e-05	2.29e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—NOTCH1—esophageal cancer	1.01e-05	2.29e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.01e-05	2.28e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—CASP8—esophageal cancer	1e-05	2.26e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—CASP8—esophageal cancer	1e-05	2.26e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1e-05	2.26e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—MYC—esophageal cancer	9.97e-06	2.25e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—SMAD4—esophageal cancer	9.97e-06	2.25e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—CREBBP—esophageal cancer	9.97e-06	2.25e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—CREBBP—esophageal cancer	9.97e-06	2.25e-05	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—EGFR—esophageal cancer	9.93e-06	2.24e-05	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—EGFR—esophageal cancer	9.93e-06	2.24e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—NOS3—esophageal cancer	9.91e-06	2.24e-05	CbGpPWpGaD
Felodipine—CALM3—Hemostasis—PIK3CA—esophageal cancer	9.9e-06	2.24e-05	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—EGFR—esophageal cancer	9.86e-06	2.23e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—EGFR—esophageal cancer	9.75e-06	2.2e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	9.72e-06	2.19e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SMAD4—esophageal cancer	9.64e-06	2.18e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SMAD4—esophageal cancer	9.64e-06	2.18e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	9.63e-06	2.18e-05	CbGpPWpGaD
Felodipine—CALM3—Hemostasis—TP53—esophageal cancer	9.58e-06	2.16e-05	CbGpPWpGaD
Felodipine—CALM2—Hemostasis—PIK3CA—esophageal cancer	9.58e-06	2.16e-05	CbGpPWpGaD
Felodipine—CALM1—Hemostasis—PIK3CA—esophageal cancer	9.58e-06	2.16e-05	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—EGFR—esophageal cancer	9.54e-06	2.15e-05	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—EGFR—esophageal cancer	9.54e-06	2.15e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GNG7—esophageal cancer	9.52e-06	2.15e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—CREBBP—esophageal cancer	9.51e-06	2.15e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—HMOX1—esophageal cancer	9.41e-06	2.13e-05	CbGpPWpGaD
Felodipine—CALM2—Hemostasis—TP53—esophageal cancer	9.26e-06	2.09e-05	CbGpPWpGaD
Felodipine—CALM1—Hemostasis—TP53—esophageal cancer	9.26e-06	2.09e-05	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—PIK3CA—esophageal cancer	9.25e-06	2.09e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—CREBBP—esophageal cancer	9.2e-06	2.08e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—CREBBP—esophageal cancer	9.2e-06	2.08e-05	CbGpPWpGaD
Felodipine—CACNA1C—Metabolism—PIK3CA—esophageal cancer	9.11e-06	2.06e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—PTGS2—esophageal cancer	9.06e-06	2.05e-05	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—TP53—esophageal cancer	8.95e-06	2.02e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.92e-06	2.01e-05	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—PIK3CA—esophageal cancer	8.91e-06	2.01e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—BCL2—esophageal cancer	8.88e-06	2.01e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—HMOX1—esophageal cancer	8.87e-06	2e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—HMOX1—esophageal cancer	8.79e-06	1.99e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—ERBB2—esophageal cancer	8.63e-06	1.95e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.62e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—PIK3CA—esophageal cancer	8.62e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—PIK3CA—esophageal cancer	8.62e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—BCL2—esophageal cancer	8.59e-06	1.94e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—BCL2—esophageal cancer	8.59e-06	1.94e-05	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—PIK3CA—esophageal cancer	8.56e-06	1.93e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—NOS3—esophageal cancer	8.52e-06	1.92e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—ABCB1—esophageal cancer	8.51e-06	1.92e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.48e-06	1.92e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—PIK3CA—esophageal cancer	8.46e-06	1.91e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—ABCB1—esophageal cancer	8.44e-06	1.91e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.38e-06	1.89e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—ERBB2—esophageal cancer	8.35e-06	1.88e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—ERBB2—esophageal cancer	8.35e-06	1.88e-05	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—PIK3CA—esophageal cancer	8.28e-06	1.87e-05	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—PIK3CA—esophageal cancer	8.28e-06	1.87e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—NOS3—esophageal cancer	8.24e-06	1.86e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—NOS3—esophageal cancer	8.24e-06	1.86e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—TP53—esophageal cancer	8.19e-06	1.85e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—HIF1A—esophageal cancer	8.15e-06	1.84e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—CREBBP—esophageal cancer	8e-06	1.81e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—CREBBP—esophageal cancer	7.97e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—ERBB2—esophageal cancer	7.97e-06	1.8e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ENO1—esophageal cancer	7.95e-06	1.8e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.95e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—HIF1A—esophageal cancer	7.89e-06	1.78e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—HIF1A—esophageal cancer	7.89e-06	1.78e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.84e-06	1.77e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PSME2—esophageal cancer	7.83e-06	1.77e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PSME1—esophageal cancer	7.83e-06	1.77e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KDR—esophageal cancer	7.8e-06	1.76e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—PTGS2—esophageal cancer	7.79e-06	1.76e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—CREBBP—esophageal cancer	7.71e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—CREBBP—esophageal cancer	7.71e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—ERBB2—esophageal cancer	7.71e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—ERBB2—esophageal cancer	7.71e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KDR—esophageal cancer	7.54e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KDR—esophageal cancer	7.54e-06	1.7e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—EP300—esophageal cancer	7.54e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—PTGS2—esophageal cancer	7.53e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—PTGS2—esophageal cancer	7.53e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—CDKN1A—esophageal cancer	7.37e-06	1.67e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—NOTCH1—esophageal cancer	7.35e-06	1.66e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—NOS3—esophageal cancer	7.16e-06	1.62e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—CDKN1A—esophageal cancer	7.13e-06	1.61e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—CDKN1A—esophageal cancer	7.13e-06	1.61e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—NOS3—esophageal cancer	7.13e-06	1.61e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—NOTCH1—esophageal cancer	7.11e-06	1.6e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—NOTCH1—esophageal cancer	7.11e-06	1.6e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—EP300—esophageal cancer	7.02e-06	1.58e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—CREBBP—esophageal cancer	6.93e-06	1.57e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—NOS3—esophageal cancer	6.9e-06	1.56e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—NOS3—esophageal cancer	6.9e-06	1.56e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—CDKN1A—esophageal cancer	6.81e-06	1.54e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—EP300—esophageal cancer	6.79e-06	1.53e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—EP300—esophageal cancer	6.79e-06	1.53e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.76e-06	1.53e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CREBBP—esophageal cancer	6.66e-06	1.5e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—CDKN1A—esophageal cancer	6.59e-06	1.49e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—CDKN1A—esophageal cancer	6.59e-06	1.49e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PTGS2—esophageal cancer	6.55e-06	1.48e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—EGFR—esophageal cancer	6.55e-06	1.48e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PTGS2—esophageal cancer	6.52e-06	1.47e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—EP300—esophageal cancer	6.48e-06	1.46e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CREBBP—esophageal cancer	6.44e-06	1.46e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CREBBP—esophageal cancer	6.44e-06	1.46e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.38e-06	1.44e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.35e-06	1.44e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—EGFR—esophageal cancer	6.33e-06	1.43e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—EGFR—esophageal cancer	6.33e-06	1.43e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PTGS2—esophageal cancer	6.31e-06	1.43e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PTGS2—esophageal cancer	6.31e-06	1.43e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—EP300—esophageal cancer	6.27e-06	1.42e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—EP300—esophageal cancer	6.27e-06	1.42e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—NOS3—esophageal cancer	6.2e-06	1.4e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—CREBBP—esophageal cancer	6.04e-06	1.36e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—EGFR—esophageal cancer	5.98e-06	1.35e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—NOS3—esophageal cancer	5.96e-06	1.35e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.8e-06	1.31e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—EGFR—esophageal cancer	5.78e-06	1.31e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—EGFR—esophageal cancer	5.78e-06	1.31e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—NOS3—esophageal cancer	5.77e-06	1.3e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—NOS3—esophageal cancer	5.77e-06	1.3e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.69e-06	1.28e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—PIK3CA—esophageal cancer	5.68e-06	1.28e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PTGS2—esophageal cancer	5.67e-06	1.28e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—MYC—esophageal cancer	5.64e-06	1.27e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.64e-06	1.27e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—ERBB2—esophageal cancer	5.58e-06	1.26e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	5.58e-06	1.26e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.57e-06	1.26e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—EGFR—esophageal cancer	5.52e-06	1.25e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—PIK3CA—esophageal cancer	5.5e-06	1.24e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—PIK3CA—esophageal cancer	5.5e-06	1.24e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—MYC—esophageal cancer	5.46e-06	1.23e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—MYC—esophageal cancer	5.46e-06	1.23e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—EP300—esophageal cancer	5.45e-06	1.23e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—EP300—esophageal cancer	5.43e-06	1.23e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—NOS3—esophageal cancer	5.41e-06	1.22e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—ERBB2—esophageal cancer	5.4e-06	1.22e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—ERBB2—esophageal cancer	5.4e-06	1.22e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—EGFR—esophageal cancer	5.34e-06	1.21e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—EGFR—esophageal cancer	5.34e-06	1.21e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—EP300—esophageal cancer	5.25e-06	1.19e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—EP300—esophageal cancer	5.25e-06	1.19e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—PIK3CA—esophageal cancer	5.19e-06	1.17e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—NOS3—esophageal cancer	5.09e-06	1.15e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—NOS3—esophageal cancer	5.05e-06	1.14e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—PIK3CA—esophageal cancer	5.02e-06	1.13e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—PIK3CA—esophageal cancer	5.02e-06	1.13e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PTGS2—esophageal cancer	4.94e-06	1.12e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CCND1—esophageal cancer	4.93e-06	1.11e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—PIK3CA—esophageal cancer	4.79e-06	1.08e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1A—esophageal cancer	4.77e-06	1.08e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CCND1—esophageal cancer	4.77e-06	1.08e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CCND1—esophageal cancer	4.77e-06	1.08e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—EP300—esophageal cancer	4.72e-06	1.07e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.66e-06	1.05e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—PIK3CA—esophageal cancer	4.64e-06	1.05e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—PIK3CA—esophageal cancer	4.64e-06	1.05e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.62e-06	1.04e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1A—esophageal cancer	4.61e-06	1.04e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1A—esophageal cancer	4.61e-06	1.04e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—EP300—esophageal cancer	4.54e-06	1.02e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—EP300—esophageal cancer	4.39e-06	9.91e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—EP300—esophageal cancer	4.39e-06	9.91e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—EP300—esophageal cancer	4.11e-06	9.29e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	4.03e-06	9.1e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CA—esophageal cancer	4.01e-06	9.06e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MYC—esophageal cancer	3.95e-06	8.93e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CA—esophageal cancer	3.88e-06	8.77e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CA—esophageal cancer	3.88e-06	8.77e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—EP300—esophageal cancer	3.87e-06	8.75e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—EGFR—esophageal cancer	3.87e-06	8.73e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—EP300—esophageal cancer	3.84e-06	8.67e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MYC—esophageal cancer	3.82e-06	8.64e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MYC—esophageal cancer	3.82e-06	8.64e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—EGFR—esophageal cancer	3.74e-06	8.45e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—EGFR—esophageal cancer	3.74e-06	8.45e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.72e-06	8.4e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.49e-06	7.88e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CA—esophageal cancer	3.36e-06	7.58e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—NOS3—esophageal cancer	3.33e-06	7.52e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TP53—esophageal cancer	3.25e-06	7.33e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CA—esophageal cancer	3.25e-06	7.33e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CA—esophageal cancer	3.25e-06	7.33e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TP53—esophageal cancer	3.14e-06	7.09e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TP53—esophageal cancer	3.14e-06	7.09e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.05e-06	6.88e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.04e-06	6.87e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.87e-06	6.47e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.84e-06	6.42e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—EP300—esophageal cancer	2.53e-06	5.72e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.87e-06	4.23e-06	CbGpPWpGaD
